期刊文献+

黄皮果提取物对急性乙醇中毒致小鼠肝损伤的保护作用 被引量:6

Protective effect of extract from fruit of Clausena lansium(Lour.) Skeels against acute alcohol-induced hepatotoxicity in mice
在线阅读 下载PDF
导出
摘要 目的探讨黄皮果提取物(EFCL)对小鼠急性乙醇中毒致肝损伤的保护作用及其可能的作用机制。方法 ICR小鼠40只,随机分为正常对照、模型及EFCL 1.5和3.0 g·kg-1组。EFCL 1.5和3.0 g·kg-1组小鼠分别ig给予相应剂量的EFCL;30 min后ig给予52℃二锅头白酒12 ml.kg-1;24 h后处死小鼠,制备血清,取肝组织制备10%肝组织匀浆,采用试剂盒方法检测血清丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)活性,以及肝组织匀浆中超氧化物歧化酶(SOD)活性、丙二醛(MDA)和谷胱甘肽(GSH)含量,常规HE染色和淀粉酶-过碘酸希夫法染色观察肝组织病理形态改变,并用免疫组织化学法测定肝组织中NF-κB和α-平滑肌肌动蛋白(α-SMA)的表达。结果与正常对照组比较,模型对照组小鼠血清ALT和AST活性分别升高28.0%和28.9%(P<0.01),肝组织匀浆中SOD活性和GSH含量分别由(706±46)kU·g-1蛋白和(251±61)mg.g-1蛋白降低至(515±68)kU·g-1蛋白和(126±18)mg.g-1蛋白,而MDA含量由(204±21)μmol·g-1蛋白升高至(258±50)μmol·g-1蛋白(P<0.05);肝组织中NF-κB和α-SMA表达增加(P<0.01)。与模型对照组比较,EFCL 1.5和3.0 g·kg-1组小鼠血清ALT活性分别降低了18.3%和19.8%,血清中AST活性分别降低了6.4%和9.7%(P<0.05,P<0.01);EFCL 3.0 g·kg-1组肝组织匀浆中GSH水平和SOD活性分别升高了61.4%和14.8%(P<0.05,P<0.01)。肝组织中NF-κB和α-SMA的表达水平明显低于模型对照组(P<0.01)。肝组织病理形态检测可见,EFCL 1.5和3.0 g·kg-1组小鼠对乙醇引起的肝细胞脂肪样变、水样变和炎症细胞浸润等均有明显改善。结论 EFCL对小鼠急性乙醇中毒所致肝损伤具有保护作用,其机制可能与升高抗氧化酶活性、促进自由基清除、降低NF-κB的表达及抑制肝星状细胞活化有关。 OBJECTIVE To study the protective effect of the extract from fruit of Clausena lansium (Lout.) Skeels (EFCL) against acute alcohol-induced hepatotoxicity in mice. METHODS The mouse model was established to use Red Star wine, its ethanol content was 52% by volume. Forty ICR mice were divided into four groups randomly: normal, model, EFCL 1.5 and 3.0 g·kg-1 groups. The mice in EFCL groups were ig given EFCL 1.5 and 3.0 g·kg-1, respectively. Thirty minutes later, wine 12 ml· kg-1 was administered to mice except in normal group. The activity of alanine transaminase (ALT) and aspartate aminotransaminase (AST) was detected in serum, and the level of superoxide dismutase ( SOD), malondialdehyde (MDA) and glu- tathione (GSH) was tested in the liver tissue with kits 24 h after wine administration. The patholog- ical changes were observed after HE and amylase-periodic acid Schiff (D-PAS) staining, and the NF-KB and a-smooth muscle actin (a-SMA) expression was detected by using immunohistochemical method. RESULTS Compared with normal group, the activities of ALT and AST were increased by 28.0% and 28.9% ( P 〈 0.01 ) in model group ; while SOD and GSH level decreased from 706±46to (515±68)kU·g-1 protein, and (251±61) to (126±18)mg·g-1 protein; MDA content increased from (204±21 ) to (258±50)Ixmol'g-1 protein (P 〈0.01 ) ; and the expression of NF-KB and a-SMA significantly increased ( P 〈 0.01 ). Compared with model group, the activity of ALT decreased by 18.3% and 19.8%, and the activity of AST decreased by 6.4% and 9.7% in EFCL 1.5 and 3.0 g'kg-1 groups (P 〈0.01, P 〈0.05) , respectively; while the levels of SOD and GSHin EFCL 3.0 g'kg-1 group averagely increased by 61.4% and 14.8% (P〈0.01, P〈 0.05). Furthermore, the severe hepatic lesions as well as neutrophilic infiltration and ballooning degenerations of hepatocytes induced by ethanol were considerably reduced in EFCL 1. 5 and 3.0 g·kg-1 groups, and the expression of NF-κB and a-SMA was significantly downregulated (P 〈 0.01 ). CONCLUSION EFCL has protective effect against acute alcohol-induced liver damage, which may be related with its downregurating the expression of NF-KB and inhibiting the proliferation of hepatic satellite cells.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2012年第6期829-834,共6页 Chinese Journal of Pharmacology and Toxicology
基金 广东省科技项目(2010A040200005) 广东省科技项目(2012B040304013) 广东医学院大学生创新实验项目(09ZZF010)~~
关键词 黄皮果 乙醇 肝损伤 抗氧化 NF-ΚB Α-平滑肌肌动蛋白 Clausena lansium (Lour.) Skeels ethanol liver injury antioxidation NF-κB or-smooth muscle actin
作者简介 官堂明(1988-),男,硕士研究生,主要从事药理学研究,Tel:13692395050,E-mail:stmgame@139.com; 通讯作者:李文德,E-mail:gdmcli@yahoo.com.cn,Tel:(0769)2388405
  • 相关文献

参考文献6

二级参考文献56

  • 1张晓岚,王占魁,姜慧卿.氧化应激与肝纤维化[J].临床肝胆病杂志,2007,23(3):226-229. 被引量:25
  • 2黄峰,何铣扬,雷艳梅.极具发展前景的山黄皮果[J].中国热带农业,2005(4):30-31. 被引量:31
  • 3孙妩弋,魏伟.肝星状细胞信号转导机制及可能的抗肝纤维化药物作用新靶点[J].中国药理学通报,2006,22(12):1433-1438. 被引量:13
  • 4Kim W H, Hong F,Jaruga B. Additive activation of hepatic NF-κB by ethanol and HBX or HCV core protein : involvement of TNF-α receptor Ⅰ-independent and-dependent mechanisms [ J ]. FASEB J, 2001,15( 13 ) :2551 - 3.
  • 5Nouchi T, Tanaka Y, Tsukada T, et al. Appearance of alpha-smooth muscle-actin-positive ceils in hepatic fibrosis [ J ]. Liver, 1991,11 (2) :100 -5.
  • 6Calabrese F, Valente M, Giacometti C, et al. Parenchymal transforming growth factor beta-1 : its type Ⅱ receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology [ J ]. J Gastroenterol Hepatol, 2003, 18 (11) :1302 -8.
  • 7Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis [ J 1. Hepatol, 1999,30 (4) :968 - 76.
  • 8Chandan G, Sankar M, Namita R C, Jayanta R C. Cell culture and animal models of viral hepatitis. Part Ⅰ : hepatitis B [ J ]. Lab Animal,2004,33(7) :37 -46.
  • 9Nada R T, Ivan V B, Dimitrije C B, et al. Activated liver stellate cells in chronic viral C hepatitis:histopathological and immunohistochemical study [ J ]. J Gastrointestin Liver Dis, 2009,18 ( 2 ) : 163 -7.
  • 10Bruha R,Dvorak K,Dousa M,et al.Alcoholic liver disease[J].Praque Med Rep,2009,110(3):181-90.

共引文献250

同被引文献47

  • 1Liu X,Wang L,Li H,et al.Coactivator-associated arginine methyltransferase 1targeted by miR-15a regulates inflammation in acute coronary syndrome[J].Atherosclerosis,2014,233(2):349-356.
  • 2Dong S,Ma W,Hao B,et al.microRNA-21 promotes cardiac fibrosis and development of heart failure withpreserved left ventricular ejection fraction by up-regulating Bcl-2[J].Int J Clin Exp Pathol,2014,7(2):565-574.
  • 3Ulivi P,Foschi G,Mengozzi M,et al.Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC[J].Int J Mol Sci,2013,14(5):10332-10342.
  • 4Sita-Lumsden A,Dart DA,Waxman J,Bevan CL.Circulating microRNAs as potential new biomarkers for prostate cancer[J].Br J Cancer,2013,108(10):1925-1930.
  • 5Giusti I,D'Ascenzo S,Dolo V.Microvesicles as potential ovarian cancer biomarkers[J].Biomed Res Int,2013,2013:703048.
  • 6Jopling CL,Norman KL,Sarnow P.Positive and negative modulation of viral and cellular mRNAs by liver-specific micromRNA miR-122[J].Cold Spring Harb Syrup Quit Biol,2006,71:369-376.
  • 7Arataki K,Hayes CN,Akamatsu S,et al.Circulating microRNA-22 correlates with microRNA-122and represents viral replication and liver injury in patients with chronic hepatitis B[J].J Med Virol,2013,85(5):789-798.
  • 8McDaniel K,Herrera L,Zhou T,et al.The functional role of microRNAs in alcoholic liver injury[J].J Cell Mol Med,2014,18(2):197-207.
  • 9Miyaaki H,Ichikawa T,Kamo Y,et al.Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease[J].Liver Int,2014,34(7):e302-307.
  • 10Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2-△△C T method[J].Methods,2001,25:402-408.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部